We are live on ! Find out more
MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

80 hedge funds and large institutions have $499M invested in Mirati Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

55% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 22

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

3% more funds holding

Funds holding: 78 → 80 (+2)

4% more capital invested

Capital invested by funds: $479M → $499M (+$20.7M)

100% less call options, than puts

Call options by funds: $5K | Put options by funds: $1.33M

Holders
80
Holders Change
+2
Holders Change %
+2.56%
% of All Funds
2.1%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
16
Increased
34
Reduced
22
Closed
14
Calls
$5K
Puts
$1.33M
Net Calls
-$1.33M
Net Calls Change
-$1.73M

Top Buyers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
+$8.83M
2
CAM
Cormorant Asset Management
Massachusetts
+$8.49M
3
State Street
State Street
Massachusetts
+$8.02M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.01M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.54M

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$11.9M
2
CCI
Columbus Circle Investors
-$10.5M
3
O
OrbiMed
New York
-$7.34M
4
ACA
Avoro Capital Advisors
New York
-$6.89M
5
EAM
EverPoint Asset Management
Connecticut
-$4.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.77M -$36.1K -1,023 -2%
RPAM
27
Rhenman & Partners Asset Management
Sweden
$1.58M – – –
BIM
28
BlackRock Investment Management
Delaware
$1.26M +$9.82K +278 +0.7%
UBS Group
29
UBS Group
Switzerland
$1.24M +$792K +22,413 +134%
TCIM
30
TIAA CREF Investment Management
New York
$1.12M +$94.2K +2,666 +8%
SIM
31
Spark Investment Management
New York
$1.03M +$1.15M +32,566 New
O
32
OrbiMed
New York
$1.02M -$7.34M -207,800 -87%
Citadel Advisors
33
Citadel Advisors
Florida
$977K -$3.22M -91,210 -75%
TI
34
Trexquant Investment
Connecticut
$945K -$219K -6,200 -17%
EI
35
EAM Investors
California
$943K +$163K +4,608 +18%
OAM
36
Oxford Asset Management
United Kingdom
$855K +$967K +27,389 New
SM
37
Sabby Management
Florida
$822K -$1.2M -33,973 -57%
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$801K +$895K +25,345 New
CS
39
Credit Suisse
Switzerland
$787K -$199K -5,625 -18%
Millennium Management
40
Millennium Management
New York
$768K +$206K +5,836 +32%
RFC
41
Russell Frank Company
Washington
$743K +$149K +4,216 +21%
TAM
42
Tocqueville Asset Management
New York
$694K +$70.6K +2,000 +10%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$673K +$10.6K +300 +1%
PP
44
PDT Partners
New York
$588K – – –
IAM
45
Integre Asset Management
New York
$582K -$207K -5,847 -24%
Charles Schwab
46
Charles Schwab
California
$571K +$134K +3,800 +27%
ACH
47
ArrowMark Colorado Holdings
Colorado
$541K – – –
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$528K +$590K +16,700 New
TA
49
Teachers Advisors
New York
$520K +$70.7K +2,002 +14%
Swiss National Bank
50
Swiss National Bank
Switzerland
$509K – – –
1
2
3 4

MRTX Hedge Fund Activity: Q4 2015 in Review

80 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Mirati Therapeutics, Inc. Common Stock (MRTX) for Q4 2015, worth a combined $499M — up 4.3% from $479M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new MRTX positions and 14 closed out — a net gain of 2 holders — while 34 added to existing stakes and 22 trimmed.

The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $8.83M. The largest seller was Citigroup, cutting an estimated $11.9M.

  • 80 institutional investors held Mirati Therapeutics, Inc. Common Stock (MRTX) as of Q4 2015, up from 78 in Q3 2015.
  • Funds reported $499M of Mirati Therapeutics, Inc. Common Stock stock for Q4 2015, up 4.3% quarter-over-quarter.
  • 16 funds opened new Mirati Therapeutics, Inc. Common Stock positions in Q4 2015 and 14 closed out, a net change of +2 holders.
  • The largest Mirati Therapeutics, Inc. Common Stock buyer in Q4 2015 was Ghost Tree Capital, an estimated $8.83M added.
  • The largest Mirati Therapeutics, Inc. Common Stock seller in Q4 2015 was Citigroup, an estimated $11.9M sold.

Based on aggregated 13F filings for Q4 2015.